Atossa Therapeutics
ATOS
#10646
Rank
NZ$42.4 M
Marketcap
NZ$4.25
Share price
-1.93%
Change (1 day)
227.92%
Change (1 year)

Atossa Therapeutics (ATOS) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$12.47 Million

According to Atossa Therapeutics's latest financial reports the company's total liabilities are NZ$12.47 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Atossa Therapeutics - Total liabilities on balance sheet (from 2010 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$14.25 M61.84%
2024-12-31NZ$8.8 M6.37%
2023-12-31NZ$8.27 M-5.59%
2022-12-31NZ$8.76 M91.63%
2021-12-31NZ$4.57 M-78.93%
2020-12-31NZ$21.71 M996.61%
2019-12-31NZ$1.98 M-54.43%
2018-12-31NZ$4.34 M151.9%
2017-12-31NZ$1.72 M14.12%
2016-12-31NZ$1.51 M-58.64%
2015-12-31NZ$3.65 M26.39%
2014-12-31NZ$2.89 M68.86%
2013-12-31NZ$1.71 M-14.64%
2012-12-31NZ$2 M3.56%
2011-12-31NZ$1.93 M72.44%
2010-12-31NZ$1.12 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$200.24 B 1,605,210.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$14.93 B 119,626.43%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.29 B 138,583.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$0.86 B 6,843.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$33.65 M 169.79%๐Ÿ‡บ๐Ÿ‡ธ USA